Objective: To investigate the roles of procalcitonin (PCT) and C-reactive protein (CRP) serum concentrations in the diagnose of urosepsis. Methods: 102(改为One hundred and two) patients with uriary tract infection (UTI) were divided into urosepsis group and non-urosepsis group. The PCT and CRP serum concentrations were compared between urosepsis group and non-urosepsis group, and the receiver operating characteristic (ROC) curves were constructed. Results: Forty-three patients were with urosepsis and 59 patients without urosepsis. Compared with the non-urosepsis group, the serum concentrations of PCT and CRP increased significantly in the urosepsis group (P<0.001). The area under ROC curve of PCT and CRP diagnosing urosepsis were 0.759 (95% CI): 0.608~0.811) and 0.710 (95% CI: 0.666~0.851), respectively. At the optimal operating points, the sensitivity, specificity, positive predictive value and negative predictive value of PCT and CRP diagnosing urosepsis were 0.907, 0.419, 0.610, 0.932, 0.629, 0.818, 0.900 and 0.688 respectively. Conclusion: PCT and CRP are effective biomarkers for urosepsis.
[1]Wacker C, Prkno A, Brunkhorst F M, et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2013, 13(5): 426.
[2]Wagenlehner F M, Lichtenstern C, Rolfes C, et al. Diagnosis and management for urosepsis[J]. Int J Urol, 2013, 20(10): 963.
[3]Wagenlehner F M, Pilatz A, Weidner W. Urosepsis--from the view of the urologist[J]. Int J Antimicrob Agents, 2011, 38(Suppl): 51.
[4]那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南(2014版) [M].北京:人民卫生出版社,2013:425[5]Sugimoto K, Adomi S, Koike H, et al. Procalcitonin as an indicator of urosepsis[J]. Res Rep Urol, 2013, 5: 77
[6]van Nieuwkoop C, Bonten T N, van’t Wout J W, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study[J]. Crit Care, 2010, 14(6): R206.
[7]Müller B, Harbarth S, Stolz D, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia[J]. BMC Infect Dis, 2007, 7: 10
[8]Luzzani A, Polati E, Dorizzi R, et al. Comparison of procalcitonin and C-reactive protein as markers of sepsis[J]. Crit Care Med, 2003, 31(6): 1737
[9]Lee H. Procalcitonin as a biomarker of infectious diseases[J]. Korean J Intern Med, 2013, 28(3): 285
[10]Wanner G A, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients[J]. Crit Care Med, 2000, 28(4): 950
[11]黄新文,王晋鹏,李海林.血清C-反应蛋白与降钙素原水平对细菌性脓毒症的诊断价值[J].中华医学杂志,2014,94(27):2106
[1]王 悦,刘德梦.泌尿系感染患者大肠埃希菌fimH基因检测及尿便来源菌株同源性分析[J].天津医科大学学报,2014,20(01):45.
WANG Yue,LIU De-meng.Examination of fimH gene of E.coli strains and the homology analysis of E.coli strains for patient s with urinary tract infections[J].Journal of Tianjin Medical University,2014,20(02):45.
作者简介 张成龙(1989-),男,硕士在读,研究方向:细菌的致病及耐药机制;
通信作者:王玉宝,E-mail:wyb2046@163.com。